Patent · US Active

MK2 inhibitors and uses thereof

US11584757B2 · kind B2 · utility

1Cited by

20References

20Claims

0Family size

Assignee

Celgene CAR LLC · BM

Inventors

Matthew D. Alexander · San Diego, US
Claudio Chuaqui · Arlington, US
John Malona · Brookline, US
Joseph McDonald · Ballwin, US
Yike Ni · Lexington, US
Deqiang Niu · Lexington, US
Russell C. Petter · Stow, US
Juswinder Singh · Southborough, US
Chittari Pabba · Slingerlands, US

Key dates

Filing date	Feb 27, 2020
Grant date	Feb 21, 2023
Priority date	—
Expiry date	Feb 27, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P37/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides compounds, compositions thereof, and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.